Buda-Nowak, A.; Kwinta, Ł.; Potocki, P.; Michałowska-Kaczmarczyk, A.; Słowik, A.; Konopka, K.; Streb, J.; Koniewski, M.; Wysocki, P.J.
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data. J. Clin. Med. 2023, 12, 1350.
https://doi.org/10.3390/jcm12041350
AMA Style
Buda-Nowak A, Kwinta Ł, Potocki P, Michałowska-Kaczmarczyk A, Słowik A, Konopka K, Streb J, Koniewski M, Wysocki PJ.
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data. Journal of Clinical Medicine. 2023; 12(4):1350.
https://doi.org/10.3390/jcm12041350
Chicago/Turabian Style
Buda-Nowak, Anna, Łukasz Kwinta, Paweł Potocki, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Joanna Streb, Maciej Koniewski, and Piotr J. Wysocki.
2023. "Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data" Journal of Clinical Medicine 12, no. 4: 1350.
https://doi.org/10.3390/jcm12041350
APA Style
Buda-Nowak, A., Kwinta, Ł., Potocki, P., Michałowska-Kaczmarczyk, A., Słowik, A., Konopka, K., Streb, J., Koniewski, M., & Wysocki, P. J.
(2023). Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data. Journal of Clinical Medicine, 12(4), 1350.
https://doi.org/10.3390/jcm12041350